首页 > 最新文献

Clinical Pathology最新文献

英文 中文
The Incidental Diagnosis of Adenomatoid Tumour on Fallopian Tubes Submitted for Tubal Ligation at a Tertiary Laboratory in Northern Pretoria, South Africa. 南非比勒陀利亚北部一家三级实验室偶然诊断出输卵管腺瘤。
IF 1.3 Q3 PATHOLOGY Pub Date : 2024-02-16 eCollection Date: 2024-01-01 DOI: 10.1177/2632010X241230265
Nosipho Maria Thobakgale, Moshawa Calvin Khaba

Introduction: Adenomatoid tumours are the most common benign mesothelial neoplasms of the fallopian tube. They are usually diagnosed incidentally in specimens submitted for bilateral tubal ligation and can be mistake for vascular or epithelial lesions.

Materials and methods: A retrospective analysis of cases with adenomatoid tumour of the fallopian submitted for tubal ligation from 2012 to 2020. The clinicopathological characteristic data was retrieved from the laboratory information system.

Results: A total of 11 cases with adenomatoid tumour of the fallopian tubes submitted for tubal ligation were identified in women with average age of 30.9 years. In all the cases, only 1 fallopian tube was affected. Grossly, the fallopian tubes did not show any discernible tumour. Immunohistochemical stains confirmed the diagnosis of adenomatoid tumours in all the cases.

Conclusion: Adenomatoid tumours in fallopian tubes are infrequent, and pathologists shouldn't overlook them especially in unsuspicious instances. As frequent as adenomatoid tumour of the fallopian tubes are uncommon, pathologists show be aware of as their misdiagnosis could lead mismanagement of patient with far reaching complication.

导言腺瘤是输卵管最常见的良性间皮瘤。它们通常在接受双侧输卵管结扎术的标本中偶然被诊断出来,可能被误认为是血管性或上皮性病变:回顾性分析 2012 年至 2020 年期间接受输卵管结扎手术的输卵管腺瘤病例。临床病理特征数据来自实验室信息系统:结果:共有11例输卵管腺瘤样肿瘤患者接受了输卵管结扎手术,患者平均年龄为30.9岁。在所有病例中,只有 1 例输卵管受到影响。从大体上看,输卵管没有任何明显的肿瘤。免疫组化染色证实了所有病例的腺瘤样肿瘤诊断:结论:输卵管腺瘤样肿瘤并不常见,病理学家不应忽视它们,尤其是在不可疑的情况下。虽然输卵管腺瘤样肿瘤并不常见,但病理学家仍应注意,因为误诊可能导致对患者的管理不善,造成深远的并发症。
{"title":"The Incidental Diagnosis of Adenomatoid Tumour on Fallopian Tubes Submitted for Tubal Ligation at a Tertiary Laboratory in Northern Pretoria, South Africa.","authors":"Nosipho Maria Thobakgale, Moshawa Calvin Khaba","doi":"10.1177/2632010X241230265","DOIUrl":"10.1177/2632010X241230265","url":null,"abstract":"<p><strong>Introduction: </strong>Adenomatoid tumours are the most common benign mesothelial neoplasms of the fallopian tube. They are usually diagnosed incidentally in specimens submitted for bilateral tubal ligation and can be mistake for vascular or epithelial lesions.</p><p><strong>Materials and methods: </strong>A retrospective analysis of cases with adenomatoid tumour of the fallopian submitted for tubal ligation from 2012 to 2020. The clinicopathological characteristic data was retrieved from the laboratory information system.</p><p><strong>Results: </strong>A total of 11 cases with adenomatoid tumour of the fallopian tubes submitted for tubal ligation were identified in women with average age of 30.9 years. In all the cases, only 1 fallopian tube was affected. Grossly, the fallopian tubes did not show any discernible tumour. Immunohistochemical stains confirmed the diagnosis of adenomatoid tumours in all the cases.</p><p><strong>Conclusion: </strong>Adenomatoid tumours in fallopian tubes are infrequent, and pathologists shouldn't overlook them especially in unsuspicious instances. As frequent as adenomatoid tumour of the fallopian tubes are uncommon, pathologists show be aware of as their misdiagnosis could lead mismanagement of patient with far reaching complication.</p>","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"17 ","pages":"2632010X241230265"},"PeriodicalIF":1.3,"publicationDate":"2024-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10874146/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139900892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RNASeq Analysis for Accurate Identification of Fusion Partners in Tumor Specific Translocations Detected by Standard FISH Probes in Hematologic Malignancies. 利用 RNASeq 分析准确识别血液恶性肿瘤中标准 FISH 探针检测到的肿瘤特异性易位中的融合伙伴。
IF 1.3 Q3 PATHOLOGY Pub Date : 2024-02-16 eCollection Date: 2024-01-01 DOI: 10.1177/2632010X241230262
Prasad Koduru, Weina Chen, Franklin Fuda, Gurbakhash Kaur, Farrukh Awan, Samuel John, Rolando Garcia, Jeffrey Gagan

Background: Fluorescence labeled DNA probes and in situ hybridization methods had shorter turn round time for results revolutionized their clinical application. Signals obtained from these probes are highly specific, yet they can produce fusion signals not necessarily representing fusion of actual genes due to other genes included in the probe design. In this study we evaluated discordance between cytogenetic, FISH and RNAseq results in 3 different patients with hematologic malignancies and illustrated the need to perform next generation sequencing (NGS) or RNASeq to accurately interpret FISH results.

Methods: Bone marrow or peripheral blood karyotypes and FISH were performed to detect recurring translocations associated with hematologic malignancies in clinical samples routinely referred to our clinical cytogenetics laboratory. When required, NGS was performed on DNA and RNA libraries to detect somatic alterations and gene fusions in some of these specimens. Discordance in results between these methods is further evaluated.

Results: For a patient with plasma cell leukemia standard FGFR3 / IGH dual fusion FISH assay detected fusion that was interpreted as FGFR3-positive leukemia, whereas NGS/RNASeq detected NSD2::IGH. For a pediatric acute lymphoblastic leukemia patient, a genetic diagnosis of PDGFRB-positive ALL was rendered because the PDGFRB break-apart probe detected clonal rearrangement, whereas NGS detected MEF2D::CSF1R. A MYC-positive B-prolymphocytic leukemia was rendered for another patient with a cytogenetically identified t(8;14) and MYC::IGH by FISH, whereas NGS detected a novel PVT1::RCOR1 not previously reported.

Conclusions: These are 3 cases in a series of several other concordant results, nevertheless, elucidate limitations when interpreting FISH results in clinical applications, particularly when other genes are included in probe design. In addition, when the observed FISH signals are atypical, this study illustrates the necessity to perform complementary laboratory assays, such as NGS and/or RNASeq, to accurately identify fusion genes in tumorigenic translocations.

背景:荧光标记的 DNA 探针和原位杂交方法可在更短的时间内得到结果,为其临床应用带来了革命性的变化。从这些探针获得的信号具有高度特异性,但由于探针设计中包含其他基因,它们可能产生不一定代表实际基因融合的融合信号。在本研究中,我们对 3 位不同血液恶性肿瘤患者的细胞遗传学、FISH 和 RNAseq 结果之间的不一致性进行了评估,并说明需要进行新一代测序(NGS)或 RNASeq 才能准确解释 FISH 结果:方法:对常规转诊至我们临床细胞遗传学实验室的临床样本进行骨髓或外周血核型和 FISH,以检测与血液恶性肿瘤相关的复发性易位。必要时,对 DNA 和 RNA 文库进行 NGS,以检测其中一些样本中的体细胞改变和基因融合。结果:对于一名浆细胞白血病患者,标准的 FGFR3 / IGH 双融合 FISH 检测发现了融合,可解释为 FGFR3 阳性白血病,而 NGS/RNASeq 检测出了 NSD2::IGH。一名小儿急性淋巴细胞白血病患者的基因诊断为 PDGFRB 阳性 ALL,因为 PDGFRB 分裂探针检测到克隆重排,而 NGS 检测到 MEF2D::CSF1R。另一名患者为 MYC 阳性 B 淋巴细胞白血病,FISH 检测出细胞遗传学 t(8;14)和 MYC::IGH,而 NGS 检测出一种新型 PVT1::RCOR1,此前未见报道:结论:这是一系列其他几个一致结果中的 3 个病例,然而,它们阐明了在临床应用中解释 FISH 结果的局限性,尤其是当探针设计中包含其他基因时。此外,当观察到的 FISH 信号不典型时,本研究说明有必要进行补充性实验室检测,如 NGS 和/或 RNASeq,以准确鉴定肿瘤易位中的融合基因。
{"title":"RNASeq Analysis for Accurate Identification of Fusion Partners in Tumor Specific Translocations Detected by Standard FISH Probes in Hematologic Malignancies.","authors":"Prasad Koduru, Weina Chen, Franklin Fuda, Gurbakhash Kaur, Farrukh Awan, Samuel John, Rolando Garcia, Jeffrey Gagan","doi":"10.1177/2632010X241230262","DOIUrl":"10.1177/2632010X241230262","url":null,"abstract":"<p><strong>Background: </strong>Fluorescence labeled DNA probes and in situ hybridization methods had shorter turn round time for results revolutionized their clinical application. Signals obtained from these probes are highly specific, yet they can produce fusion signals not necessarily representing fusion of actual genes due to other genes included in the probe design. In this study we evaluated discordance between cytogenetic, FISH and RNAseq results in 3 different patients with hematologic malignancies and illustrated the need to perform next generation sequencing (NGS) or RNASeq to accurately interpret FISH results.</p><p><strong>Methods: </strong>Bone marrow or peripheral blood karyotypes and FISH were performed to detect recurring translocations associated with hematologic malignancies in clinical samples routinely referred to our clinical cytogenetics laboratory. When required, NGS was performed on DNA and RNA libraries to detect somatic alterations and gene fusions in some of these specimens. Discordance in results between these methods is further evaluated.</p><p><strong>Results: </strong>For a patient with plasma cell leukemia standard <i>FGFR3</i> / <i>IGH</i> dual fusion FISH assay detected fusion that was interpreted as <i>FGFR3</i>-positive leukemia, whereas NGS/RNASeq detected <i>NSD2::IGH</i>. For a pediatric acute lymphoblastic leukemia patient, a genetic diagnosis of <i>PDGFRB</i>-positive ALL was rendered because the <i>PDGFRB</i> break-apart probe detected clonal rearrangement, whereas NGS detected <i>MEF2D::CSF1R</i>. A <i>MYC</i>-positive B-prolymphocytic leukemia was rendered for another patient with a cytogenetically identified t(8;14) and <i>MYC::IGH</i> by FISH, whereas NGS detected a novel <i>PVT1::RCOR1</i> not previously reported.</p><p><strong>Conclusions: </strong>These are 3 cases in a series of several other concordant results, nevertheless, elucidate limitations when interpreting FISH results in clinical applications, particularly when other genes are included in probe design. In addition, when the observed FISH signals are atypical, this study illustrates the necessity to perform complementary laboratory assays, such as NGS and/or RNASeq, to accurately identify fusion genes in tumorigenic translocations.</p>","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"17 ","pages":"2632010X241230262"},"PeriodicalIF":1.3,"publicationDate":"2024-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10874141/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139900891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dietary Salt Can Be Crucial for Food-Induced Vascular Inflammation. 膳食盐对食物诱发的血管炎症至关重要
IF 1.3 Q3 PATHOLOGY Pub Date : 2024-02-03 eCollection Date: 2024-01-01 DOI: 10.1177/2632010X241228039
Syed Masudur Rahman Dewan, Sara Shahid Meem, Amrin Yeasin Proma, Mohammad Shahriar

Salt enhances the taste as well as the nutritional value of food. Besides, several reports are available on the incidence and epidemiology of various illnesses in relation to salt intake. Excessive salt consumption has been found to be linked with high blood pressure, renal disease, and other cardiovascular disorders due to the result of vascular inflammation. Nevertheless, studies aimed at elucidating the molecular processes that produce vascular inflammation have yet to reach their conclusions. This article emphasizes the significance of investigating the mechanisms underlying both acute and chronic vascular inflammation induced by salt. It also explores the logical inferences behind cellular oxidative stress and the role of endothelial dysfunction as the potential initiator of the inflammatory segments that remain poorly understood. It is therefore hypothesized that salt is one of the causes of chronic vascular inflammation such as atherosclerosis. The hypothesis's secrets, when revealed, can help assure cardiovascular health by proactive efforts and the development of appropriate preventative measures, in combination with medication, dietary and lifestyle adjustments.

食盐能提升食物的口感和营养价值。此外,有多份报告指出,各种疾病的发病率和流行病学与食盐摄入量有关。研究发现,过量摄入食盐与高血压、肾病和其他心血管疾病有关,这些疾病是血管炎症的结果。然而,旨在阐明产生血管炎症的分子过程的研究尚未得出结论。本文强调了研究盐诱发急性和慢性血管炎症机制的重要性。文章还探讨了细胞氧化应激背后的逻辑推理,以及内皮功能障碍作为炎症环节潜在启动器的作用,但这些问题仍然鲜为人知。因此,假设盐是动脉粥样硬化等慢性血管炎症的原因之一。一旦揭示了这一假设的秘密,就可以通过积极的努力和制定适当的预防措施,结合药物、饮食和生活方式的调整,帮助确保心血管健康。
{"title":"Dietary Salt Can Be Crucial for Food-Induced Vascular Inflammation.","authors":"Syed Masudur Rahman Dewan, Sara Shahid Meem, Amrin Yeasin Proma, Mohammad Shahriar","doi":"10.1177/2632010X241228039","DOIUrl":"10.1177/2632010X241228039","url":null,"abstract":"<p><p>Salt enhances the taste as well as the nutritional value of food. Besides, several reports are available on the incidence and epidemiology of various illnesses in relation to salt intake. Excessive salt consumption has been found to be linked with high blood pressure, renal disease, and other cardiovascular disorders due to the result of vascular inflammation. Nevertheless, studies aimed at elucidating the molecular processes that produce vascular inflammation have yet to reach their conclusions. This article emphasizes the significance of investigating the mechanisms underlying both acute and chronic vascular inflammation induced by salt. It also explores the logical inferences behind cellular oxidative stress and the role of endothelial dysfunction as the potential initiator of the inflammatory segments that remain poorly understood. It is therefore hypothesized that salt is one of the causes of chronic vascular inflammation such as atherosclerosis. The hypothesis's secrets, when revealed, can help assure cardiovascular health by proactive efforts and the development of appropriate preventative measures, in combination with medication, dietary and lifestyle adjustments.</p>","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"17 ","pages":"2632010X241228039"},"PeriodicalIF":1.3,"publicationDate":"2024-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10838034/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139681931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Artificial Intelligence (AI) Technology in Healthcare Sector: A Critical Evaluation of Both Sides of the Coin. 人工智能(AI)技术对医疗保健行业的影响:对硬币两面的批判性评估。
IF 1.9 Q3 PATHOLOGY Pub Date : 2024-01-22 eCollection Date: 2024-01-01 DOI: 10.1177/2632010X241226887
Md Ashrafur Rahman, Evangelos Victoros, Julianne Ernest, Rob Davis, Yeasna Shanjana, Md Rabiul Islam

The influence of artificial intelligence (AI) has drastically risen in recent years, especially in the field of medicine. Its influence has spread so greatly that it is determined to become a pillar in the future medical world. A comprehensive literature search related to AI in healthcare was performed in the PubMed database and retrieved the relevant information from suitable ones. AI excels in aspects such as rapid adaptation, high diagnostic accuracy, and data management that can help improve workforce productivity. With this potential in sight, the FDA has continuously approved more machine learning (ML) software to be used by medical workers and scientists. However, there are few controversies such as increased chances of data breaches, concern for clinical implementation, and potential healthcare dilemmas. In this article, the positive and negative aspects of AI implementation in healthcare are discussed, as well as recommended some potential solutions to the potential issues at hand.

近年来,人工智能(AI)的影响力急剧上升,尤其是在医学领域。人工智能的影响力已经如此之大,以至于它将成为未来医学世界的支柱。我们在 PubMed 数据库中对与医疗保健领域的人工智能相关的文献进行了全面搜索,并从合适的文献中检索到了相关信息。人工智能在快速适应、高诊断准确性和数据管理等方面表现出色,有助于提高工作效率。鉴于这一潜力,美国食品和药物管理局不断批准更多机器学习(ML)软件供医务工作者和科学家使用。然而,也存在一些争议,如数据泄露的几率增加、临床实施方面的担忧以及潜在的医疗困境。本文将讨论人工智能在医疗保健领域应用的积极和消极方面,并推荐一些解决当前潜在问题的潜在方案。
{"title":"Impact of Artificial Intelligence (AI) Technology in Healthcare Sector: A Critical Evaluation of Both Sides of the Coin.","authors":"Md Ashrafur Rahman, Evangelos Victoros, Julianne Ernest, Rob Davis, Yeasna Shanjana, Md Rabiul Islam","doi":"10.1177/2632010X241226887","DOIUrl":"10.1177/2632010X241226887","url":null,"abstract":"<p><p>The influence of artificial intelligence (AI) has drastically risen in recent years, especially in the field of medicine. Its influence has spread so greatly that it is determined to become a pillar in the future medical world. A comprehensive literature search related to AI in healthcare was performed in the PubMed database and retrieved the relevant information from suitable ones. AI excels in aspects such as rapid adaptation, high diagnostic accuracy, and data management that can help improve workforce productivity. With this potential in sight, the FDA has continuously approved more machine learning (ML) software to be used by medical workers and scientists. However, there are few controversies such as increased chances of data breaches, concern for clinical implementation, and potential healthcare dilemmas. In this article, the positive and negative aspects of AI implementation in healthcare are discussed, as well as recommended some potential solutions to the potential issues at hand.</p>","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"17 ","pages":"2632010X241226887"},"PeriodicalIF":1.9,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10804900/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139543565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The WHO has Declared COVID-19 is No Longer a Pandemic-Level Threat: A Perspective Evaluating Potential Public Health Impacts. 世卫组织宣布 COVID-19 不再是大流行级别的威胁:评估潜在公共卫生影响的视角》。
IF 1.9 Q3 PATHOLOGY Pub Date : 2024-01-22 eCollection Date: 2024-01-01 DOI: 10.1177/2632010X241228053
Asm Roknuzzaman, Rapty Sarker, Nazmunnahar, Mohammad Shahriar, Rana Al Mosharrafa, Md Rabiul Islam
{"title":"The WHO has Declared COVID-19 is No Longer a Pandemic-Level Threat: A Perspective Evaluating Potential Public Health Impacts.","authors":"Asm Roknuzzaman, Rapty Sarker, Nazmunnahar, Mohammad Shahriar, Rana Al Mosharrafa, Md Rabiul Islam","doi":"10.1177/2632010X241228053","DOIUrl":"10.1177/2632010X241228053","url":null,"abstract":"","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"17 ","pages":"2632010X241228053"},"PeriodicalIF":1.9,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10804921/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139543567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kinetics of IL-6, C-reactive Protein and Fibrinogen Levels in COVID-19 Outpatients Who Evolved to Hypoxemia. COVID-19 低氧血症门诊患者体内 IL-6、C 反应蛋白和纤维蛋白原水平的动力学变化。
IF 1.3 Q3 PATHOLOGY Pub Date : 2024-01-03 eCollection Date: 2024-01-01 DOI: 10.1177/2632010X231222795
Sérgio Paulo de Mello Mendes-Filho, Rebeca de Souza Pinheiro, Fernanda Simão Martins, Paulo Jose Giroldi, Raul Honorato E Melo, Edcleia Lopes de Oliveira, Anibal Borin Dos Santos, Dayse Cristina Oliveira Medeiros, Jéssica Amaral Lopes, Yury Oliveira Chaves, Juliana Pavan Zuliani, Paulo Afonso Nogueira

Introduction: Despite the efficacy of the COVID-19, the search for improvements in the management of severe/critical cases continues to be important. The aim is to demonstrate the kinetics of 4 serological markers in patients with COVID-19 who evolved in hypoxemia.

Methods: From June to December 2020, the Health Secretariat of Rondônia State, Brazil, established a home medical care service team (HMCS) that provided clinical follow-up for health professionals and military personnel with COVID-19. The clinical and laboratory monitoring was individualized at home by a nursing and medical team. In addition to laboratory parameters, C-reactive protein (CRP), interleukin-6 (IL-6), fibrinogen, and D-dimer levels were periodically taken to monitor the evolution of treatment.

Results: Of 218 patients telemonitored, 48 patients needed special care by the HMCS team due to shortness of breath. Chest tomography showed multiple ground-glass shadows and lung parenchymal condensations that was compatible with secondary bacterial infection associated with leukocytosis, for which antibiotics were prescribed. The symptoms were accompanied by increases of CRP and IL-6 levels followed by fibrinogen after a few days, for which an anticoagulant therapy was included. Thirty-three patients evolved to improvements in clinical signs and laboratory results. Between the sixth and eighth day of illness, 15 patients presented signs of hypoxemia with low O2 saturation accompanied with an increase in the respiratory rate, with some of them requiring oxygen therapy. As they did not present signs of clinical severity, but their laboratory markers showed an abrupt IL-6 peak that was higher than the increase in CRP and a new alteration in fibrinogen levels, they received a supplemental dose of anticoagulant and a high dose of corticosteroids, which resulted in clinical improvement.

Conclusion: Our study demonstrates that monitoring of IL-6 and CRP may identify precocious hypoxemia in COVID-19 patients and prevented the progressive deterioration of the lung injury.

导言:尽管 COVID-19 疗效显著,但如何改善重症/危重症病例的治疗仍然非常重要。本研究旨在展示 COVID-19 患者在低氧血症演变过程中 4 种血清学标志物的动力学:2020年6月至12月,巴西朗多尼亚州卫生秘书处成立了一个家庭医疗服务团队(HMCS),为感染COVID-19的卫生专业人员和军人提供临床随访。护理和医疗团队在家中进行个性化的临床和实验室监测。除实验室指标外,还定期检测 C 反应蛋白 (CRP)、白细胞介素-6 (IL-6)、纤维蛋白原和 D-二聚体水平,以监测治疗进展:在接受远程监控的 218 名患者中,有 48 名患者因呼吸急促而需要接受 HMCS 团队的特别护理。胸部断层扫描显示多处磨玻璃阴影和肺实质凝结,这与继发性细菌感染和白细胞增多相吻合,并为此开出了抗生素处方。这些症状伴随着 CRP 和 IL-6 水平的升高,几天后纤维蛋白原也升高了,因此需要进行抗凝治疗。有 33 名患者的临床症状和实验室结果有所改善。发病第六天至第八天期间,15 名患者出现低氧血症症状,血氧饱和度低,呼吸频率增加,其中一些患者需要吸氧治疗。由于他们没有出现严重的临床症状,但其实验室指标显示 IL-6 突然达到峰值,且高于 CRP 的升高,纤维蛋白原水平也出现了新的变化,因此他们接受了补充剂量的抗凝剂和大剂量皮质类固醇,结果临床症状得到了改善:我们的研究表明,监测 IL-6 和 CRP 可以识别 COVID-19 患者的早发性低氧血症,并防止肺损伤逐渐恶化。
{"title":"Kinetics of IL-6, C-reactive Protein and Fibrinogen Levels in COVID-19 Outpatients Who Evolved to Hypoxemia.","authors":"Sérgio Paulo de Mello Mendes-Filho, Rebeca de Souza Pinheiro, Fernanda Simão Martins, Paulo Jose Giroldi, Raul Honorato E Melo, Edcleia Lopes de Oliveira, Anibal Borin Dos Santos, Dayse Cristina Oliveira Medeiros, Jéssica Amaral Lopes, Yury Oliveira Chaves, Juliana Pavan Zuliani, Paulo Afonso Nogueira","doi":"10.1177/2632010X231222795","DOIUrl":"10.1177/2632010X231222795","url":null,"abstract":"<p><strong>Introduction: </strong>Despite the efficacy of the COVID-19, the search for improvements in the management of severe/critical cases continues to be important. The aim is to demonstrate the kinetics of 4 serological markers in patients with COVID-19 who evolved in hypoxemia.</p><p><strong>Methods: </strong>From June to December 2020, the Health Secretariat of Rondônia State, Brazil, established a home medical care service team (HMCS) that provided clinical follow-up for health professionals and military personnel with COVID-19. The clinical and laboratory monitoring was individualized at home by a nursing and medical team. In addition to laboratory parameters, C-reactive protein (CRP), interleukin-6 (IL-6), fibrinogen, and D-dimer levels were periodically taken to monitor the evolution of treatment.</p><p><strong>Results: </strong>Of 218 patients telemonitored, 48 patients needed special care by the HMCS team due to shortness of breath. Chest tomography showed multiple ground-glass shadows and lung parenchymal condensations that was compatible with secondary bacterial infection associated with leukocytosis, for which antibiotics were prescribed. The symptoms were accompanied by increases of CRP and IL-6 levels followed by fibrinogen after a few days, for which an anticoagulant therapy was included. Thirty-three patients evolved to improvements in clinical signs and laboratory results. Between the sixth and eighth day of illness, 15 patients presented signs of hypoxemia with low O<sub>2</sub> saturation accompanied with an increase in the respiratory rate, with some of them requiring oxygen therapy. As they did not present signs of clinical severity, but their laboratory markers showed an abrupt IL-6 peak that was higher than the increase in CRP and a new alteration in fibrinogen levels, they received a supplemental dose of anticoagulant and a high dose of corticosteroids, which resulted in clinical improvement.</p><p><strong>Conclusion: </strong>Our study demonstrates that monitoring of IL-6 and CRP may identify precocious hypoxemia in COVID-19 patients and prevented the progressive deterioration of the lung injury.</p>","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"17 ","pages":"2632010X231222795"},"PeriodicalIF":1.3,"publicationDate":"2024-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10768631/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139378801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intra-Articular Calcaneus Osteoid Osteoma With an Ankle Varus and a Red-Brown Synovial Fluid in the Affected Joint, a Case Report. 伴有踝关节内翻和受累关节红褐色滑液的关节内骨样骨瘤,病例报告。
IF 1.3 Q3 PATHOLOGY Pub Date : 2023-12-25 eCollection Date: 2023-01-01 DOI: 10.1177/2632010X231220198
Dat Quoc Ngo, Thi Cao

Background: Only one article described ankle varus as a typical symptom in the late stage of the intra-articular osteoid osteoma of the calcaneus. And the red-brown color of synovial fluid in the affected joint hasn't been reported. This report shows a patient with intra-articular osteoid osteoma of the calcaneus who had the 2 above symptoms.

Case presentation: A 39-year-old man had left ankle pain and the diagnosis was delayed for 20 months. At the late stage, the ankle was gradually varus. In our hospital, the withdrawal of the subtalar joint gave a red-brown synovial fluid. Together with the typical lesion on MRI, the diagnosis of intra-articular osteoid osteoma of the calcaneus was made. An open operation was performed for treatment. In the procedure, the red-brown synovial fluid was exuded. A specimen was harvested for biopsy confirming osteoid osteoma.

Conclusions: It is still essential that intra-articular calcaneal osteoid osteoma should be considered in patients with prolonged pain and varus of the ankle. The red-brown synovial may be used as a finding for diagnosis.

背景:只有一篇文章描述了踝关节屈曲是小关节内骨样骨瘤晚期的典型症状。而受累关节的滑液呈红褐色也未见报道。本报告显示的是一名具有上述两种症状的小关节内类骨骨瘤患者:一名 39 岁的男子左脚踝疼痛,诊断延误了 20 个月。晚期,踝关节逐渐外翻。在我院,足底关节抽出的滑液呈红褐色。结合核磁共振的典型病变,诊断为小腿骨关节内骨样骨瘤。为治疗进行了开刀手术。在手术过程中,渗出了红褐色的滑液。采集的标本经活检证实为类骨瘤:结论:对于长期疼痛和踝关节外翻的患者,考虑关节内小关节骨样骨瘤仍然非常重要。红褐色滑膜可作为诊断依据。
{"title":"Intra-Articular Calcaneus Osteoid Osteoma With an Ankle Varus and a Red-Brown Synovial Fluid in the Affected Joint, a Case Report.","authors":"Dat Quoc Ngo, Thi Cao","doi":"10.1177/2632010X231220198","DOIUrl":"10.1177/2632010X231220198","url":null,"abstract":"<p><strong>Background: </strong>Only one article described ankle varus as a typical symptom in the late stage of the intra-articular osteoid osteoma of the calcaneus. And the red-brown color of synovial fluid in the affected joint hasn't been reported. This report shows a patient with intra-articular osteoid osteoma of the calcaneus who had the 2 above symptoms.</p><p><strong>Case presentation: </strong>A 39-year-old man had left ankle pain and the diagnosis was delayed for 20 months. At the late stage, the ankle was gradually varus. In our hospital, the withdrawal of the subtalar joint gave a red-brown synovial fluid. Together with the typical lesion on MRI, the diagnosis of intra-articular osteoid osteoma of the calcaneus was made. An open operation was performed for treatment. In the procedure, the red-brown synovial fluid was exuded. A specimen was harvested for biopsy confirming osteoid osteoma.</p><p><strong>Conclusions: </strong>It is still essential that intra-articular calcaneal osteoid osteoma should be considered in patients with prolonged pain and varus of the ankle. The red-brown synovial may be used as a finding for diagnosis.</p>","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"16 ","pages":"2632010X231220198"},"PeriodicalIF":1.3,"publicationDate":"2023-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10750543/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139040899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Global Impact of COVID-19: Historical Development, Molecular Characterization, Drug Discovery and Future Directions. COVID-19 的全球影响:历史发展、分子特征、药物发现和未来方向。
IF 1.9 Q3 PATHOLOGY Pub Date : 2023-12-23 eCollection Date: 2023-01-01 DOI: 10.1177/2632010X231218075
Aboagye Kwarteng Dofuor, Naa Kwarley-Aba Quartey, Angelina Fathia Osabutey, Belinda Obenewa Boateng, Hanif Lutuf, Joseph Harold Nyarko Osei, Selina Mawunyo Ayivi-Tosuh, Albert Fynn Aiduenu, William Ekloh, Seyram Kofi Loh, Maxwell Jnr Opoku, Owusu Fordjour Aidoo

In December 2019, an outbreak of a respiratory disease called the coronavirus disease 2019 (COVID-19) caused by a new coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in Wuhan, China. The SARS-CoV-2, an encapsulated positive-stranded RNA virus, spread worldwide with disastrous consequences for people's health, economies, and quality of life. The disease has had far-reaching impacts on society, including economic disruption, school closures, and increased stress and anxiety. It has also highlighted disparities in healthcare access and outcomes, with marginalized communities disproportionately affected by the SARS-CoV-2. The symptoms of COVID-19 range from mild to severe. There is presently no effective cure. Nevertheless, significant progress has been made in developing COVID-19 vaccine for different therapeutic targets. For instance, scientists developed multifold vaccine candidates shortly after the COVID-19 outbreak after Pfizer and AstraZeneca discovered the initial COVID-19 vaccines. These vaccines reduce disease spread, severity, and mortality. The addition of rapid diagnostics to microscopy for COVID-19 diagnosis has proven crucial. Our review provides a thorough overview of the historical development of COVID-19 and molecular and biochemical characterization of the SARS-CoV-2. We highlight the potential contributions from insect and plant sources as anti-SARS-CoV-2 and present directions for future research.

2019 年 12 月,中国武汉开始暴发由一种名为严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)的新型冠状病毒引起的呼吸道疾病--冠状病毒病 2019(COVID-19)。SARS-CoV-2 是一种包裹的正链 RNA 病毒,它在全球范围内传播,给人们的健康、经济和生活质量带来了灾难性后果。该疾病对社会产生了深远的影响,包括经济混乱、学校停课、压力和焦虑增加。它还凸显了医疗保健服务和结果方面的差异,边缘化社区受到 SARS-CoV-2 的影响尤为严重。COVID-19 的症状从轻微到严重不等。目前还没有有效的治疗方法。不过,针对不同治疗目标开发 COVID-19 疫苗的工作已取得重大进展。例如,在辉瑞和阿斯利康发现最初的 COVID-19 疫苗后,科学家们在 COVID-19 爆发后不久就开发出了多种候选疫苗。这些疫苗减少了疾病的传播、严重程度和死亡率。事实证明,在 COVID-19 诊断的显微镜检查之外增加快速诊断方法至关重要。我们的综述全面概述了 COVID-19 的历史发展以及 SARS-CoV-2 的分子和生化特征。我们强调了昆虫和植物来源作为抗 SARS-CoV-2 的潜在贡献,并提出了未来研究的方向。
{"title":"The Global Impact of COVID-19: Historical Development, Molecular Characterization, Drug Discovery and Future Directions.","authors":"Aboagye Kwarteng Dofuor, Naa Kwarley-Aba Quartey, Angelina Fathia Osabutey, Belinda Obenewa Boateng, Hanif Lutuf, Joseph Harold Nyarko Osei, Selina Mawunyo Ayivi-Tosuh, Albert Fynn Aiduenu, William Ekloh, Seyram Kofi Loh, Maxwell Jnr Opoku, Owusu Fordjour Aidoo","doi":"10.1177/2632010X231218075","DOIUrl":"10.1177/2632010X231218075","url":null,"abstract":"<p><p>In December 2019, an outbreak of a respiratory disease called the coronavirus disease 2019 (COVID-19) caused by a new coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in Wuhan, China. The SARS-CoV-2, an encapsulated positive-stranded RNA virus, spread worldwide with disastrous consequences for people's health, economies, and quality of life. The disease has had far-reaching impacts on society, including economic disruption, school closures, and increased stress and anxiety. It has also highlighted disparities in healthcare access and outcomes, with marginalized communities disproportionately affected by the SARS-CoV-2. The symptoms of COVID-19 range from mild to severe. There is presently no effective cure. Nevertheless, significant progress has been made in developing COVID-19 vaccine for different therapeutic targets. For instance, scientists developed multifold vaccine candidates shortly after the COVID-19 outbreak after Pfizer and AstraZeneca discovered the initial COVID-19 vaccines. These vaccines reduce disease spread, severity, and mortality. The addition of rapid diagnostics to microscopy for COVID-19 diagnosis has proven crucial. Our review provides a thorough overview of the historical development of COVID-19 and molecular and biochemical characterization of the SARS-CoV-2. We highlight the potential contributions from insect and plant sources as anti-SARS-CoV-2 and present directions for future research.</p>","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"16 ","pages":"2632010X231218075"},"PeriodicalIF":1.9,"publicationDate":"2023-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10748929/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139032884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Elevated Serum Macrophage Migration Inhibitory Factor Levels are Associated With Major Depressive Disorder. 血清巨噬细胞迁移抑制因子水平升高与重度抑郁症有关。
IF 1.3 Q3 PATHOLOGY Pub Date : 2023-12-23 eCollection Date: 2023-01-01 DOI: 10.1177/2632010X231220841
Kaniz Farzana Supti, Md Asaduzzaman, Farhana Islam Suhee, Mohammad Shahriar, Sardar Mohammad Ashraful Islam, Mohiuddin Ahmed Bhuiyan, Mma Shalahuddin Qusar, Md Rabiul Islam

Background: Previous studies have suggested the involvement of an activated inflammatory process in major depressive disorder (MDD), as altered expression of inflammatory cytokines is observed in depression. This alteration can be the cause or a consequence of MDD. However, acknowledging inflammatory cytokines as prospective biomarkers would aid in diagnosing or guiding better therapeutic options. Therefore, we designed this study to assess the macrophage migration inhibitory factor (MIF) in depression.

Method: We collected blood samples from 115 MDD patients and 113 healthy controls (HCs) matched by age and sex. MDD patients were diagnosed by a qualified psychiatrist based on the symptoms mentioned in the diagnostic and statistical manual of mental disorders (DSM-5). We applied the Hamilton depression (Ham-D) rating scale to assess the severity of depression. We assessed serum levels of MIF using ELISA kit (Boster Bio, USA).

Result: We detected increased serum MIF levels in MDD patients compared to HCs (6.15 ± 0.23 ng/mL vs 3.95 ± 0.21 ng/mL, P < 0.001). Moreover, this increase is more among female patients than female controls. Also, we noticed a positive correlation between altered MIF levels and the Ham-D scores (r = 0.233; P = 0.012), where we found that patients who scored higher on the Ham-D scale had higher MIF levels in serum. Moreover, the area under the curve (AUC) of receiver operating characteristic (ROC) curve represented the good diagnostic performance of altered serum MIF.

Conclusion: Our study findings indicate the association of pro-inflammatory cytokine MIF in the pathophysiology of depression as we identified elevated serum MIF levels in depressive patients compared to HCs. However, more researches are required to confirm whether this alteration of cytokine is the causative factor or a consequence of depression. We recommend conducting further studies to understand the pattern of this alteration of MIF levels in MDD patients.

背景:以往的研究表明,重度抑郁症(MDD)与激活的炎症过程有关,因为在抑郁症中观察到炎症细胞因子的表达发生了改变。这种变化可能是重度抑郁症的原因,也可能是其结果。然而,承认炎性细胞因子是前瞻性生物标志物将有助于诊断或指导更好的治疗方案。因此,我们设计了这项研究来评估抑郁症患者体内的巨噬细胞迁移抑制因子(MIF):方法:我们收集了 115 名 MDD 患者和 113 名健康对照者(HCs)的血样,他们的年龄和性别均匹配。MDD患者由合格的精神科医生根据《精神障碍诊断与统计手册》(DSM-5)中提到的症状进行诊断。我们采用汉密尔顿抑郁量表(Ham-D)来评估抑郁的严重程度。我们使用 ELISA 试剂盒(美国博斯特生物公司)评估血清中 MIF 的水平:结果:与普通人相比,我们检测到 MDD 患者血清中 MIF 水平升高(6.15 ± 0.23 ng/mL vs 3.95 ± 0.21 ng/mL,P r = 0.233;P = 0.012),其中我们发现在 Ham-D 量表中得分较高的患者血清中 MIF 水平较高。此外,接收者操作特征曲线(ROC)的曲线下面积(AUC)表明血清 MIF 的变化具有良好的诊断性能:我们的研究结果表明,与普通人相比,抑郁症患者的血清 MIF 水平升高,这表明促炎细胞因子 MIF 与抑郁症的病理生理学有关。然而,这种细胞因子的变化是抑郁症的致病因素还是后果,还需要更多的研究来证实。我们建议开展进一步研究,以了解 MDD 患者 MIF 水平变化的模式。
{"title":"Elevated Serum Macrophage Migration Inhibitory Factor Levels are Associated With Major Depressive Disorder.","authors":"Kaniz Farzana Supti, Md Asaduzzaman, Farhana Islam Suhee, Mohammad Shahriar, Sardar Mohammad Ashraful Islam, Mohiuddin Ahmed Bhuiyan, Mma Shalahuddin Qusar, Md Rabiul Islam","doi":"10.1177/2632010X231220841","DOIUrl":"https://doi.org/10.1177/2632010X231220841","url":null,"abstract":"<p><strong>Background: </strong>Previous studies have suggested the involvement of an activated inflammatory process in major depressive disorder (MDD), as altered expression of inflammatory cytokines is observed in depression. This alteration can be the cause or a consequence of MDD. However, acknowledging inflammatory cytokines as prospective biomarkers would aid in diagnosing or guiding better therapeutic options. Therefore, we designed this study to assess the macrophage migration inhibitory factor (MIF) in depression.</p><p><strong>Method: </strong>We collected blood samples from 115 MDD patients and 113 healthy controls (HCs) matched by age and sex. MDD patients were diagnosed by a qualified psychiatrist based on the symptoms mentioned in the diagnostic and statistical manual of mental disorders (DSM-5). We applied the Hamilton depression (Ham-D) rating scale to assess the severity of depression. We assessed serum levels of MIF using ELISA kit (Boster Bio, USA).</p><p><strong>Result: </strong>We detected increased serum MIF levels in MDD patients compared to HCs (6.15 ± 0.23 ng/mL vs 3.95 ± 0.21 ng/mL, <i>P</i> < 0.001). Moreover, this increase is more among female patients than female controls. Also, we noticed a positive correlation between altered MIF levels and the Ham-D scores (<i>r</i> = 0.233; <i>P</i> = 0.012), where we found that patients who scored higher on the Ham-D scale had higher MIF levels in serum. Moreover, the area under the curve (AUC) of receiver operating characteristic (ROC) curve represented the good diagnostic performance of altered serum MIF.</p><p><strong>Conclusion: </strong>Our study findings indicate the association of pro-inflammatory cytokine MIF in the pathophysiology of depression as we identified elevated serum MIF levels in depressive patients compared to HCs. However, more researches are required to confirm whether this alteration of cytokine is the causative factor or a consequence of depression. We recommend conducting further studies to understand the pattern of this alteration of MIF levels in MDD patients.</p>","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"16 ","pages":"2632010X231220841"},"PeriodicalIF":1.3,"publicationDate":"2023-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10748934/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139032883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: How Is Gallbladder Metastasis From Renal Cell Carcinoma Depicted on Ultrasound? 致编辑的信:超声如何描绘肾细胞癌的胆囊转移?
IF 1.3 Q3 PATHOLOGY Pub Date : 2023-11-30 eCollection Date: 2023-01-01 DOI: 10.1177/2632010X231218074
Taketoshi Fujimoto
{"title":"Letter to the Editor: How Is Gallbladder Metastasis From Renal Cell Carcinoma Depicted on Ultrasound?","authors":"Taketoshi Fujimoto","doi":"10.1177/2632010X231218074","DOIUrl":"10.1177/2632010X231218074","url":null,"abstract":"","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"16 ","pages":"2632010X231218074"},"PeriodicalIF":1.3,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687913/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138464333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1